
Maven backs £12m MBO of Westfield Medical
Maven Capital Partners has backed the management buyout of Westfield Medical, a UK provider of sterilisation packaging products for the healthcare and industrial sectors, in a £12m deal.
Upon completion of the transaction, Westfield will invest in its production facilities and look to expand its international sales.
The deal marks just the third transaction of the year for Maven. The GP supported the £11m MBO of EE Smith Contracts in February and the following month exited Dantec Hose to German trade buyer Elaflex-Gummi Ehlers – a sale that saw it reap a 2.1x return.
PNC provided a senior debt package in addition to working capital facilities to support the transaction.
Company
Founded in the 1970s and headquartered in Radstock, near Bath, Westfield produces sterilisation products for use in both the industrial and healthcare sectors. Its clients include the UK National Health Service, private hospitals and companies involved in the production of medical devices. Around half its revenues are generated from international sales.
People
Maven – Andrew Ferguson (partner).
Westfield Medical – Patrick Sparkes (managing director).
Advisers
Equity – Spectrum Corporate Finance (corporate finance); RSM (financial due diligence); CIL (commercial due diligence); JLY (insurance due diligence); Gateley (legal).
Vendor – Clearwater International (corporate finance); Bird & Bird (legal).
Debt – Squire Patton Boggs (legal).
Management – Pitmans (legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater